{"id":"W4387135691","doi":"10.1136/ijgc-2023-esgo.879","title":"#487 ARTISTRY-7: a phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68)","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre; Hamilton Health Sciences","funders":"","keywords":"Pembrolizumab; Medicine; Ovarian cancer; Oncology; Internal medicine; Tolerability; Fallopian tube; Carboplatin; Chemotherapy; Bevacizumab; Phases of clinical research; Cancer; Immunotherapy; Cisplatin; Surgery; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001445727,0.001302946,0.001880886,0.0004481776,0.000431069,0.001032827,0.0009870515,0.001402163,0.004470255],"category_scores_gemma":[0.0007958213,0.0005140241,0.00173883,0.0003425975,0.001046276,0.0009511345,0.0003360076,0.003888815,0.00118463],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000819898,"about_ca_system_score_gemma":0.001553781,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001439045,"about_ca_topic_score_gemma":0.004384199,"domain_scores_codex":[0.9996246,0.0001937874,0.00001386213,0.00004986103,0.00002919208,0.00008869138],"domain_scores_gemma":[0.999474,0.00009546136,0.00008092735,0.00003597659,0.00003198067,0.0002818042],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8140479,0.05481404,0.004397501,0.001161002,0.002680886,0.0001891162,0.0003102479,0.002215671,0.02460418,0.0005633984,0.007051129,0.08796498],"study_design_scores_gemma":[0.7649559,0.224464,0.00540863,0.00004279921,0.0006150589,0.0001184055,0.00007406036,0.0009165806,0.001186366,0.0001887889,0.002001903,0.00002737614],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989548,0.002965586,0.000452761,0.0008219944,0.0002713664,0.001903352,0.001390464,0.0001374357,0.002509247],"genre_scores_gemma":[0.9831281,0.002801369,0.00205199,0.001731741,0.0002913965,0.002726682,0.002892566,0.00005730947,0.004318865],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004470255,"threshold_uncertainty_score":0.01495451,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02622351390052871,"score_gpt":0.3356447379003544,"score_spread":0.3094212239998257,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}